Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors

Saro H. Armenian
Melissa M. Hudson
Renee L. Mulder
Ming Hui Chen
Louis S. Constine
Mary Dwyer
Paul C. Nathan
Wim J.E. Tissing
Sadhna Shankar, George Washington University
Elske Sieswerda
Rod Skinner
Julia Steinberger
Elvira C. van Dalen
Helena van der Pal
W. Hamish Wallace
Gill Levitt
Leontien C.M. Kremer

Document Type

Journal Article

Publication Date

3-1-2015

Journal

Lancet Oncology

Volume

Volume 16, Issue 3

Issue

3

Inclusive Pages

e123-e136

Keywords

Anthracyclines--adverse effects; Antibiotics, Antineoplastic--adverse effects; Cardiomyopathies--diagnosis; Diagnostic Imaging--standards; Neoplasms--drug therapy; Neoplasms--radiotherapy; Radiation Injuries--diagnosis; Survivors

Comments

PMCID: PMC4485458 [Available on 2016-03-01]

APA Citation

Armenian, S.H., Hudson, M.M., Mulder, R.L., Chen, M.H., Constine, L.S. et al. (2015). Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncology, 16(3), e123-e126.

Peer Reviewed

1